Tech Company Financing Transactions
Redbud Medicine Funding Round
Redbud Medicine, based in Beijing, secured $10 million in investment from Delian Capital, Hongfeng Capital and MING Bioventures.
Transaction Overview
Company Name
Announced On
9/12/2022
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to streamline execution of clinical trials from protocol design, CRF creation, and ongoing medical review through the final CSR.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
No. 5 Kaituo Road, Haidian District
Beijing, 100089
CN
Beijing, 100089
CN
Phone
Undisclosed
Website
Email Address
Overview
Provider of clinical trial services designed for pharmaceutical and biotechnology industries. The company optimizes and accelerates clinical trials, enabling clients to lower the operation cost and accelerate the clinical study process.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Meng Fu
Browse more venture capital transactions:
Prev: 9/12/2022: Bitsy's venture capital transaction
Next: 9/12/2022: Lumafield venture capital transaction
Share this article
About Our VC Transactions Data
We report on all VC transactions involving tech companies. All VC database entries on this site are derived from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs